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ABSTRACT 
Studies of outcomes associated with the provision of genetic counseling services began to 
emerge in the 1990’s. The goals of this outcome-based research are often focused on examining 
the effectiveness of the services offered and determining appropriate means for improvement of 
services. The outcomes measured vary depending on the specific goals of the study and beliefs 
concerning the nature of counseling. Research utilizing outcome measurements choose the most 
appropriate measurement based on the desired goal of the research. This study employed a client 
satisfaction measurement, specifically a Satisfaction with Genetic Counseling Scale (SGCS), a 
self-reporting measure provided to clients in the form of a survey who were seen at the 
Huntington Disease Specialty Clinic in Pittsburgh, Pennsylvania. The hypothesis for this study 
was that patients in the HD Clinic are generally satisfied with the genetic counseling services 
they have received. Descriptive statistics were used to measure the general satisfaction and test 
the hypothesis. Responses to open-ended questions were categorized into themes to gather more 
insight into patient perceptions of genetic counseling services. Thirty-three individuals 
completed the survey, and analysis of the results revealed that patients are generally satisfied 
with the genetic counseling. Results were broken down into subscales measuring general 
satisfaction of inherent characteristics of a genetic counselor and attributes specific to the 
counseling. Patients were overall generally satisfied with each subscale. This research is of 
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particular significance to the field of public health because assessing the provision of genetic 
counseling services ensures that clients’ needs are being met as well identifies potential avenues 
for improvement of services. Research of this nature is becoming increasingly more important 
because genetic counselors, with their expertise in molecular diagnosis, are expected to play an 
essential role in providing personalized and preventative health care in the growing field of 
genome-guided medicine. This research may inform outcome research in other settings, 
providing additional insight to the genetic counseling field.   
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1.0  INTRODUCTION 
Huntington disease (HD) is an inherited, progressive neurodegenerative condition characterized 
by motor disturbances, behavioral changes, and cognitive decline. The disease results from an 
expanded CAG repeat in the huntingtin (HTT) gene located on chromosome 4. In the general 
population, individuals carry on average 17-20 CAG repeats in this gene. Individuals with >40 
repeats will develop HD with nearly 100% certainty. The individuals who inherit the disease 
progress from completely asymptomatic to presenting with symptoms that worsen in severity 
over time. Early signs of the disease generally present by the age of 40, with death typically 
occurring 15-20 years after the age of diagnosis. The prognosis is poor, and there still remains no 
cure for the disease; however, treatment is available pharmacologically and 
nonpharmacologically for management of some of the symptoms (Dayalu & Albin, 2015).  
Families can face a number of challenges after receiving a diagnosis of HD. At-risk 
individuals are often burdened with the complexity of living in the shadow of risk for developing 
HD, some families are placed in the position of being caregivers for those affected with HD, 
which can create psychological stress, and family dynamics can transform significantly leading 
to unexpected consequences such as divorce. Health care and support provided to families with 
HD has the potential to alleviate some of these stressors, which is the intent of the Huntington 
Disease Clinic of UPMC in Pittsburgh, Pennsylvania. The clinic is a dedicated resource for 
families with HD in Western Pennsylvania and the geographical surrounding areas.  
 1 
Genetic counseling has been an integral service provided in the UPMC HD Clinic and in 
the broader HD community for greater than twenty years. Genetic counselors have collaborated 
with the Western Pennsylvania Chapter of the Huntington Disease Society of America (HDSA) 
to provide services in the Clinic. Predictive testing, one of the services offered in the clinic, is 
available to at-risk individuals. Recognizing the potential psychological impact of learning one’s 
risk status, a predictive testing protocol was developed by the HDSA. Genetic counseling is an 
important component of this protocol (Meyers et al., 2003).  
Although HD predictive testing has been available for greater than twenty years, minimal 
research has been conducted to evaluate the effectiveness of genetic counseling services within a 
HD clinic setting. This type of outcome research is important to ensure that patients and their 
families affected with HD are receiving the genetic counseling services necessary in order to 
enhance their coping and minimize the stressors and impacts that a diagnosis may have on a 
family.  
1.1 HYPOTHESIS AND SPECIFIC AIMS 
1.1.1 Hypothesis 
Patients in the Huntington Disease Clinic of UPMC in Pittsburgh, Pennsylvania are generally 
satisfied with the genetic counseling services that they have received.  
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1.1.2 Specific Aims 
Aim 1: To evaluate the effectiveness of genetic counseling services by distributing a client 
satisfaction survey to patients or their family members/caregivers receiving these services from 
the Huntington Disease Clinic of UPMC in Pittsburgh, Pennsylvania. 
 
Aim 2: To statistically analyze the results from the client satisfaction survey to evaluate the 
effectiveness of the genetic counseling services offered through the Huntington Disease Clinic of 
UPMC in Pittsburgh, Pennsylvania. 
1.2 BACKGROUND AND SIGNIFICANCE  
1.2.1 Huntington Disease 
Huntington disease (HD) is an inherited, progressive neurodegenerative condition characterized 
by motor disturbances, behavioral changes, and cognitive decline. It is estimated to affect 
approximately 30,000 individuals in the United States and Canada. Approximately 150,000 
individuals are at risk for inheriting the disease. HD most frequently affects individuals of 
European decent, which the prevalence is considered to be about 10 to 15 per 100,000 (Dayalu & 
Albin, 2015). 
A clinical triad is often used to characterize the features associated with Huntington 
disease. Progressive motor disorder is one part of the triad. Perhaps the most recognizable feature 
of HD is the chorea movements, which remain only a small part of the motor dysfunction but can 
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be the most debilitating. Chorea often begins as fidgety movements most visible in the distal 
extremities. As the disease progresses, the chorea often becomes more pronounced involving 
larger, proximal muscles. Individuals may experience other motor difficulties including saccadic 
eye movements, dystonia, bradykinesia, and ataxia of speech, limbs or gait. Progressive motor 
function can lead to even more serious complications as the disease progresses. Individuals often 
have significant weight loss and aspiration as a result of dysphagia. Additionally, the progressive 
motor failure and chorea can be accident-provoking leading to serious injury (Dayalu & Albin, 
2015).  
The second part of the clinical triad is the cognitive disorder. The cognitive decline 
culminates in dementia, which serves as a significant disturbance to an individual’s daily living. 
It typically presents early in an individual’s life, affecting the capability to complete normal 
activities. Multitasking, focus, short-term memory, and learning new skills are also difficulties 
individuals may experience and may affect social as well as occupational functioning (Dayalu & 
Albin, 2015).  
The third part of the clinical triad in HD is the psychiatric changes that may include 
behavioral problems, anxiety disorders, delusional behavior, or hallucinations. As with all of the 
features associated with Huntington disease, the degree and symptoms of the psychiatric 
disturbances varies between individuals. Some individuals experience significant depression, 
obsessive-compulsive behaviors, irritability, and outbursts not consistent with their typical 
personality type. Individuals receiving a diagnosis of HD should be monitored for suicide, as the 
rate is increased for individuals receiving a new diagnosis (Dayalu & Albin, 2015).  
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1.2.1.1 Molecular Genetics   
Huntington disease is as an autosomal dominant disorder. The majority of cases are 
caused by the inheritance of the expanded allele from an affected parent. However, 
approximately 10% of cases result from a new expansion in an individual. The disease results 
from an expanded CAG repeat in the huntingtin (HTT) gene located on chromosome 4. The 
length of the CAG repeat is associated with the age of onset and presence of symptoms. In the 
general population, individuals carry on average 17-20 CAG repeats in this gene. Typically, 
individuals with 6-26 CAG repeats are considered in the normal range and will not develop the 
disease. Those with 27-35 repeats are considered in the intermediate range. Generally these 
individuals do not develop HD; however, there have been a few reported cases in the literature. 
An allele with a repeat size in the intermediate range is considered unstable and has the chance to 
expand in future generations to a disease causing repeat number. Studies have shown that this 
happens more frequently when transmitted through a male parent. Moreover, a repeat number in 
the range of 36-39 is considered the ‘gray zone’.  Individuals with a repeat number in this range 
may or may not develop the disease as a result of incomplete penetrance. However, CAG repeats 
>40 indicate that the individual will develop HD in their lifetime with nearly 100% certainty.  
Highly expanded repeat numbers are associated with an early age of onset of HD 
symptoms. Individuals with a highly expanded repeat number, >60, generally develop symptoms 
at an early age compared to others with a lower number of repeats. The reason for this is 
unknown at this time. Individuals with <45 CAG repeats have a more variable age of onset. 
Smaller repeat lengths such as <45 are more common than highly expanded repeat numbers. 
Furthermore, age of onset may be influenced by other genetic and environmental factors, to 
which the extent is currently unknown (Dayalu & Albin, 2015). 
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1.2.1.2 Treatment and Management 
At present, there is no cure for HD. Pharmacologic treatments and nonpharmacologic 
supportive measures are used for symptom management.  
Pharmacologic treatments are mainly directed towards psychiatric symptoms due to the 
adequate response to treatment. Additionally, there are pharmacologic treatments for chorea 
movements. These treatments seem to reduce chorea but do not completely eliminate it from the 
individual’s symptomatology.  
Nonpharmacologic management may include comprehensive care by a wide range of 
specialists including but not limited to: primary care physicians, neurologists, psychiatrists, 
geneticists, physical and occupational therapists, speech pathologists, nutritionists, social 
workers, and genetic counselors. Nondrug interventions are just as important as pharmacologic 
treatments in the care of an individual with HD. Physical and occupational therapy is vital for 
management of gait disturbances and modifications to the home that are important for the safety 
of the individual as the disease progresses. Speech therapy may be necessary for an individual 
for management of dysarthria and dysphagia. A nutritionist often manages dietary concerns, 
particularly regarding extreme weight loss. Social workers and counselors participate in 
managing the complex needs and psychosocial concerns an individual with HD or their family 
has before and after receiving a diagnosis (Dayalu & Albin, 2015).  
The management for an individual with HD is complex and requires the attention of 
multiple health care professionals. Care and treatment should be tailored to the specific 
individual. Given that there is no cure for the disease and pharmacotherapy is solely focused on 
managing symptoms, research is currently centered on identifying a disease-modifying therapy 
(Dayalu & Albin, 2015).  
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1.2.2 The Role of Genetic Counseling in Huntington Disease 
Predictive genetic testing is currently being offered for a variety of different conditions including 
single gene disorders, such as Huntington disease, and other conditions such as hereditary cancer 
predispositions. HD paved the way in predictive genetic testing, having been the first predictive 
testing program offered to individuals who are at risk. Predictive genetic testing has the potential 
to engender emotional, cognitive, and behavioral sequelae in the individual undergoing testing. It 
is recommended that HD predictive testing be offered within a predictive testing protocol due to 
the complexities that are potentially involved in the process (Broadstock et al., 2000). This 
predictive testing protocol includes elaborate pre- and post- test evaluations, which includes 
genetic counseling, to ensure that the individual desiring the predictive testing is making an 
informed choice, is competent enough to receive their results, and to reduce the risk of adverse 
psychological consequences as a result of the testing (i.e. severe depression, suicidality) (Grubs 
et al., 2014).  
The Huntington Disease Society of America (HDSA) published a revised protocol in 
2003 for predictive genetic testing in HD. The HDSA recommends these guidelines but states 
that they may need adapted by a health care professional according to the clinic of care or the 
individual seeking the testing. The predictive testing protocol recommended by the HDSA can be 
seen below in Table 1: 
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Table 1. HDSA Recommended Predictive Testing Protocol 
Genetic counselors have a number of responsibilities in the predictive genetic testing process. 
The HDSA describes the roles of genetic counseling in the predictive testing process as follows:  
 
“This includes a review of the family history, confirmation of the family diagnosis, and 
 explanation of the applicant’s risk status. Genetic principles that relate to HD as the gene 
 test are reviewed, including the risks, benefits, and limitations of the test (such as the 
 possibility of results in the intermediate range, or the inability to predict the age of onset 
 based on repeat number alone). Alternatives to genetic testing are discussed. Often the 
 genetic counselor will explore the applicant’s experience with HD and perceptions of the 
 disease, and discuss the potential burden of the test results on the individual and the 
 family. Pre-test tasks are discussed and scheduled or performed if necessary (such as 
 identifying a local counselor, confirming the family diagnosis by testing an affected 
 person, evaluating neurological or psychiatric symptoms, or obtaining insurance).” 
 
The above quotation from the HDSA delineates the importance of genetic counseling in 
the HD predictive genetic testing protocol. Outcome research on the effectiveness of genetic 
counseling in a HD setting is important to ensure that the counseling is fulfilling its role in the 
predictive genetic testing process. Due to the major involvement of genetic counseling in the 
predictive testing protocol, an outcome study of client satisfaction involving the elucidation of 
patients’ perceptions in the setting of the Huntington Disease Clinic of UPMC would identify 
areas of proficiencies and areas in need of improvement. In addition, the results of this study 
have the potential to contribute information not only for genetic counseling in its involvement 
with HD predictive genetic testing but also with predictive testing in other specialties of genetic 
counseling. Discovering inherent characteristics of a genetic counselor and components of a 
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genetic counseling session in which patients are most satisfied with is applicable knowledge for 
any specialty of genetic counseling. In an era where consumer-oriented practice is becoming 
more commonplace, outcome measure research utilizing client satisfaction in genetic counseling 
will become increasingly more important.  
1.2.3 Huntington Disease Clinic of UPMC: Pittsburgh, Pennsylvania  
The Huntington Disease Clinic of UPMC in Pittsburgh, Pennsylvania offers predictive and 
confirmatory/diagnostic genetic testing and counseling to individuals affected with HD, or those 
at-risk, and their families. Additionally, the clinic provides comprehensive care for individuals 
with HD in Pittsburgh and surrounding regions. When appropriate, patients are offered the 
opportunity to participate in HD-related research. Leaders in the field of HD, Robert Y. Moore, 
MD, Professor of Neurology, and Elizabeth Gettig, MS, LCGC founded the clinic.  Presently, the 
clinic is still providing services under the direction of Valerie R. Suski, DO, Assistant Professor 
of Neurology.  
The clinic offers support and resources for individuals and their families affected by HD.  
Contributing to the care of these individuals in this center are physicians, genetic counselors, 
social workers, and research coordinators. Comprehensive care is provided to ensure that 
individuals receive the tailored care necessary in the management of their disease. Among the 
services offered are the following: neurological evaluation, genetic counseling, pharmacologic 
treatment for movement disorders and psychiatric symptoms, cognitive and psychiatric 
evaluation, physical, occupational, and speech therapy, caregiver services, social services, and 
nutritional counseling. Additionally, this center is a leader in Huntington disease research and 
offers individuals the opportunity to participate in clinical trials and research studies.  
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1.3 OUTCOME MEASURES IN GENETIC COUNSELING 
Outcome measures in genetic counseling are designed with the goal of evaluating counseling 
effectiveness in meeting client needs as well as discovering areas for improvement in the 
delivery of counseling services. The evaluation of genetic counseling largely depends on the 
belief about the nature and the goals of the counseling (Pilnick and Dingwall, 2001). Pilnick and 
Dingwall (2001) noted that the outcome measures used most frequently in studies measuring 
counseling effectiveness are centered on reproductive decision-making, anxiety reduction, and 
client satisfaction. However, other studies have focused on client information recall as a means 
for studying counseling effectiveness. This is largely due in part to the fact that one aspect of a 
genetic counselor’s role is educational in nature. Given the transmission of factual information in 
genetic counseling interactions, measuring client information recall is one logical approach to 
measuring counseling effectiveness. Additionally, genetic counseling has obvious psychological 
consequences for the client following the delivery of particularly difficult information. Outcome 
measures such as an individual’s general wellbeing and perceived personal control (PPC) may be 
most appropriate in settings where clients’ psychological consequences are of interest to the 
researcher (Davey et al., 2005). Ultimately, the appropriate outcome measure to be used in a 
study is largely dependent on the client population, the specific intent of the study, and the 
beliefs about the nature and goals of the counseling. 
Historically, outcome research in genetic counseling has rarely been performed in the 
setting of the Huntington disease population. In this study, we chose to use the outcome measure 
of client satisfaction to evaluate the effectiveness of the genetic counseling services offered in 
the Huntington Disease Clinic of UPMC in Pittsburgh, Pennsylvania. For the purposes of this 
thesis, various outcome measures are briefly discussed to explicate why we felt client satisfaction 
 10 
was the most appropriate measurement to be used in satisfying the aims of this study. For each of 
the outcome measures discussed, the literature extends beyond the scope of this paper. 
References to appropriate literature are provided should further research on the specific outcome 
measure be desired.  
1.3.1.1 Knowledge Measures  
Knowledge outcome measures have been used historically as a means of evaluating the 
effectiveness of genetic counseling services. One aim of genetic counseling is to aid in patient 
informed decision making by helping the patient to “comprehend the medical facts, including the 
diagnosis, the probable course of the disorder and the available management.” (Michie et al., 
1997). In some respects, knowledge measures as part of outcome research are used to measure 
the extent to which patients receiving genetic counseling are informed after receiving those 
services. Several knowledge scales have been developed and validated for target populations as a 
means of using this measure in outcome research. However, researchers in the field are generally 
moving away from this measure in evaluating genetic counseling services. One reason is that 
relevant knowledge is perceived differently among individuals, and groups, particularly when 
from different cultures. Therefore, it has been argued that transferring knowledge measures 
between research studies is fairly difficult (Kasparian et al., 2007).  
A comprehensive literature review on knowledge measures is beyond the scope of this 
thesis. However, the following references provide additional information regarding this measure: 
Lippman-Hand et al., 1979, Michie et al., 1997, Pilnick, A., & Dingwall, R., 2001, Rowley et al., 
1984, Seidenfield, MJ. & Antley, RM., 1981, and Sorenson et al., 1981, Clarke et al. 1996, 
Drake et al. 1999; Hunter et al. 2005; Pieterse et al. 2007, Armeli et al. 2005; Decruyenaere et al. 
1992; Gordon et al. 2003; Grody et al. 1997; Leonard et al. 1995; Meiser et al. 2005; Sujansky et 
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al. 1990, Ondrusek et al. 1999, Miller et al. 2005a, Warner et al. 2003, Erblich et al. 2005, 
Marteau et al. 1988, Lesser & Rabinowitz 2001, Goel et al. 1996, Rostant et al. 2003.   
1.3.1.2 Decision-related Measures  
Client decision-making is often a central component of genetic counseling interactions. In 
general, two different approaches are used in research to evaluate decision-making and a client’s 
satisfaction with his/her decision. One approach that does not appear to have been used to date in 
settings of genetic counseling is assessing patient satisfaction with the decision-making process. 
Reasons for this are unclear. However, scales have been developed for the purpose of this 
measurement. Additionally, several scales have been developed to measure a second approach 
used in research regarding decision-making and client satisfaction. These involve assessing 
outcomes to a client’s decision as well as investigating client’s evaluations of their decisions 
(Kasparian et al., 2007). See the following references for a more thorough discussion of 
decision-related outcome measures: Miller & Starr, 1967, Sainfort & Booske 2000, Pierce 1993, 
Holmes-Rovner et al., 1996, Green et al., 2004, Nagle et al., 2006, O’Connor 1997, O’Connor 
1995, O’Connor et al. 1998, O’Connor et al. 2006, Drake et al. 1999, Hunter et al. 2005, Kaiser 
et al. 2002, Matloff et al. 2006, Peterson et al. 2006, Schwartz et al. 2001, Tiller et al. 2006, 
Wakefield et al. 2007, Mancini et al. 2006, Brehaut et al. 2003, Stalmeier et al. 2005, Michie et 
al. 2002, Jaques et al. 2005, and Rowe et al. 2006.  
1.3.1.3 Psychological Adjustment Measures  
Self-reporting measures have been developed in outcome research for the purpose of 
identifying individuals that may be psychologically impacted by genetic risk assessment. 
Conveying genetic information in a genetic counseling session has the potential to significantly 
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impact the psychological wellbeing of a client. For example, one may think of counseling a 
client regarding familial cancer risk to be taxing on the client’s psychological state. These 
measures have also been utilized in the setting of genetic counseling to identify clients who may 
benefit from additional interventions or more thorough psychological evaluation. A number of 
scales have been developed that are either tailored to a specific hereditary condition or provide a 
general indication of psychological distress (Kasparian et al., 2007).    
An individual affected with Huntington disease may have an altered psychological state 
as a consequence of the disease. The validity of a study may be questioned when an outcome 
measure studying the effectiveness of genetic counseling utilizes the psychological state of a 
client. The psychological state of the individual would potentially serve as a confounding 
variable in the study, unless this variable is controlled for in an appropriate manner. The 
following references provide a more thorough discussion of different scales that have been 
developed: Zigmond and Snaith 1983, Bjelland et al. 2002, Keller et al. 2002, Nordin et al. 2002, 
Lobb et al. 2002a, Lodder et al. 2001, Reichelt et al. 2004, Chapman and Bilton 2004, 
Spielberger 1983, Hunter et al. 2005, Tercyak et al. 2001b, van Zuuren 1993, Meiser et al. 2005, 
Nisselle et al. 2004, Brain et al. 2002, Cull et al. 1999, Huiart et al. 2002, Julian-Reynier et al. 
1999, Watson et al. 1999, Pieterse et al. 2007, Grosfeld et al. 2000, Gordon et al. 2003, Grody et 
al. 1997, Decruyenaere et al. 2003, Marteau and Bekker 1992, Radloff 1977, Myers and 
Weissman 1980, McDowell and Newell 1996,  Verdier-Taillefer et al. 2001, Weissman et al. 
1977, Vadaparampil et al. 2005, Lerman et al. 1997b, McBride et al. 2002, Horowitz et al. 1979, 
Cella et al. 1990, Zilberg et al. 1982, Schwartz et al. 2003b, Cella et al. 2002, Skirton 2001,  Roy 
and Andrews 1999, Read et al. 2005.  
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1.3.1.4 Perceived Personal Control (PPC)  
Perceived Personal Control (PPC) is an outcome measure studying whether a client feels 
he/she possesses the appropriate knowledge, support system, and resources necessary to respond 
to a stressor in their life in a way that decreases its negative effect. Specifically, it is an outcome 
measure that examines an individual’s response to an event that is occurring in their life. In a 
genetic counseling context, outcome research utilizes cognitive and decisional components of 
PPC that serve as predictors of satisfaction with genetic counseling services (Davey et al., 2005).   
An individual affected with Huntington disease may have an altered psychological state 
and cognitive disorder as a consequence of the disease. The validity of a study may be 
questioned when it uses an outcome measure studying the effectiveness of genetic counseling on 
the psychological wellbeing of a client. Furthermore, considering a cognitive disorder is one part 
of the clinical triad of Huntington disease, PPC would not be an appropriate outcome measure in 
this study. PPC as an outcome measure incorporates a cognitive component referring to an 
individual’s ability to process information in a way to alleviate some stress from a stressful 
situation. As individuals with HD progress into the later stages of disease, decision-making and 
cognitive abilities diminish. Hence, PPC as an outcome measure was deemed not appropriate for 
the HD population. However, the following references will provide more details regarding 
Perceived Personal Control as an outcome measure: Shiloh et al. 2002, Thompson et al. 1993, 
Taylor 1983, Berkenstadt et al. 1999, Averill 1973, Carver 1997, Carver et al. 1989, Helder et al. 
2002, Biesecker et al. 2000, Tercyak et al. 2004, Scheier and Carver 1985, Scheier et al. 1994, 
Smith et al. 1989, Miller 1987, 1995, 1996, Miller and Mangan 1983, Steptoe and O’Sullivan 
1986, Lerman et al. 1993, Miller et al. 1988, Phipps and Zinn 1986; van Zuuren 1993, Tercyak et 
al. 2001b, Christensen et al. 1997, Tercyak et al. 2001c.   
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1.3.1.5 Perceived Risk and Risk Accuracy Measures  
There are different methodological approaches that have been developed for assessing a 
client’s perceived risk after receiving genetic counseling. Frequently, perceived lifetime risk for 
developing a hereditary condition is evaluated. This is often done using a visual analog scale. 
Additionally, some outcome research is also done to evaluate or assess accuracy of perceived 
risk, especially in circumstances when accurate objective risk estimates for a condition are 
known. A comprehensive review of this literature is beyond the scope of this thesis. The 
following references provide detailed information on this outcome measure: Kasparian et al., 
2007, Killgore 1999, McCormack et al. 1988, Miller and Ferris 1993, Nyenhuis et al. 1997, 
Wewers and Lowe 1990, Codori et al. 2001, Epstein et al. 1997, McCaul et al. 1996, Schwartz et 
al. 2003a, Marteau et al. 1991, Tercyak et al. 2001b, Lerman et al. 1997b, Watson et al. 1999, 
McBride et al. 2002, Miller et al. 2005b, Erblich et al. 2000, Kent et al. 2000, Lloyd et al. 1996, 
Meiser et al. 2000, Rees et al. 2004, Zakowski et al. 1997, Julian-Reynier et al. 1999.  
1.3.1.6 Family Functioning and Family Communication Measures  
Genetic counseling outcome measures that assess a family’s communication pattern and 
dynamics pre- and post- counseling is a challenging process and are mostly done in the setting of 
hereditary cancer predispositions. Kasparian et al., 2007 states that “…the aim of past research 
has been to: (1) characterize the patterns of family functioning for those families presenting for 
genetic counseling (Koehly et al. 2003); (2) describe the extent to which family members 
communicate with one another about genetic counseling and/or genetic test results (Hughes et al. 
2002; McGivern et al. 2004); (3) describe the nature of, and motivations for, family 
communication about genetic risk (Hughes et al. 2002; McGivern et al. 2004); and (4) identify 
the various “roles” played by different members within a family (e.g. caretaker, informer; 
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DudokdeWit et al. 1997; Foster et al. 2004; Koehly et al. 2003).” Given the difficulty in the 
utilization of this outcome measure as well as its lack of use in populations other than hereditary 
cancer populations, this outcome measure was not chosen for this study. More detailed 
information about this outcome measure may be found in the following references: Koehly et al. 
2003, McInerney-Leo et al. 2005, Peterson et al. 2003, Green et al. 1997, Julian-Reynier et al. 
2000, 1996, Lerman et al. 1998, Wilson et al. 2004, Blandy et al. 2003, Foster et al. 2004, Gaff et 
al. 2005, Hallowell et al. 2005, Hamilton et al. 2005, Kenen et al. 2004, Bowen et al. 2004, Claes 
et al. 2003, Hughes et al. 1999, Tercyak et al. 2001a, 2002, Koehly et al. 2003, Hughes et al. 
2002, McGivern et al. 2004, DudokdeWit et al. 1997, Mesters et al. 1997, van Oostrom et al. 
2007a, b, 2003, Cappelli et al. 2005, Skinner et al. 1995, Olson et al. 1985, Hudson 1992, 
Holahan and Moos 1986, Beavers et al. 1985.  
1.3.1.7 Client Satisfaction  
Shiloh et al. (1990) developed a client satisfaction outcome measure to evaluate the 
effectiveness of genetic counseling services. In their study, the aim was to design a questionnaire 
and to elicit patient satisfaction by administering the questionnaire to 76 clients in a genetic 
counseling center as well as to 56 parents in a pediatric outpatient clinic, which served as the 
control group. The researchers wanted to determine the quality and outcome of genetic 
counseling by studying clients’ general level of satisfaction. Additionally, they were interested in 
determining the composition and determinants of satisfaction in a genetic counseling setting. 
They constructed a measure of satisfaction using three components of satisfaction: instrumental, 
affective, and procedural. Instrument refers to a client’s perspective on the healthcare 
professional possessing the required skills necessary in the delivery of services. The affective 
component relates to the healthcare professional showing affect in the delivery of services, 
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specifically exhibiting interest and care. Lastly, the procedural component refers to the 
administrative aspect of the delivery of the services. 
Client satisfaction has not been widely used in genetic counseling outcome research. 
Shiloh et al. (1990) suggest that this measure is not commonly used due to a “lack of an 
acceptable measure of this factor”. In other words, they argue that a standardized measure of 
satisfaction in a genetic counseling setting has not been developed. Shiloh et. al. (1990) state that 
their study developed a measure of satisfaction that is standardized and acceptable for use in 
client satisfaction outcome research.  
Presently, debate still exists over the use of client satisfaction as a measure for evaluating 
effectiveness in genetic counseling. Several factors complicate its use as an outcome measure. 
Genetic counseling is believed to be less satisfying than other medical services from a client 
perspective. Often, clients are not receiving their desired outcome of the services; i.e. receiving 
results of genetic testing that may not explain an adverse health outcome. Additionally, genetic 
counselors often provide information to a family that is perceived negatively by clients. These 
two factors may confound or negatively impact the judgment of clients and affect their 
evaluation of the genetic counseling services. The evaluation may not adequately reflect their 
view of the service itself. Rather, their negative interpretation of the information delivered to 
them resulted in an undesirable evaluation of the services.  
Despite these concerns for utilizing patient satisfaction in outcome research, in this study 
we adapted the Shiloh et al. (1990) comprehensive measure of satisfaction. This was deemed 
appropriate for the HD population for multiple reasons. Measuring client satisfaction allows for 
adequate evaluation of genetic counseling services and is not dependent on psychological or 
cognitive abilities of the client. Rather, the study utilized two of the three components of 
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satisfaction including instrumental and affective. Additionally, considering the central role 
genetic counseling has in the predictive testing process, client perceptions of genetic counseling 
services and their satisfaction with these services are important in ensuring the genetic counselor 
is providing satisfactory services and meeting clients’ expectations. Outcome research on genetic 
counseling in the HD population has not been completed to date and a client satisfaction 
outcome study would contribute knowledge on the effectiveness of counseling in a predictive 
testing setting. The results of the study have the potential to inform outcome research conducted 
in other predictive testing settings. In addition, the ease of obtaining satisfaction data is ideal in a 
patient population whose mental capacity could be too limited to participate in outcome research 
using measures that rely on cognitive processes such as knowledge measures. Individuals 
affected with HD or their family members or caregivers can easily assess the components of 
satisfaction, therefore making satisfaction an appropriate outcome measure for this study. 
Outcome measures such as decision-related measures, perceived risk and risk accuracy 
measures, and family functioning and family communication measures may be appropriate in a 
HD setting for other research studies. However, the goal of this research was to determine 
effectiveness of counseling services by utilizing and determining patient perceptions. A 
satisfaction outcome measure was considered the most appropriate measure in order to achieve 
the aims of this research.  
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2.0  MATERIALS AND METHODS  
This thesis project was reviewed by the University of Pittsburgh’s Institutional Review Board 
and was determined to meet criteria for exemption (Appendix A).  
2.1 PARTICIPANTS 
This research study sought to elicit perceptions of satisfaction with genetic counseling from three 
groups of individuals: individuals affected with Huntington disease, family members (individuals 
at-risk based on their family history of HD), or caregivers for individuals with HD. Several 
groups of participants were recruited for this study. Individuals who attend the monthly 
Huntington Disease (HD) Clinic of UPMC in Pittsburgh, Pennsylvania and received genetic 
counseling services were invited to participate in the study. Individuals with Huntington disease 
who were members of the Pittsburgh Institute for Neurodegenerative Diseases (PIND) 
Movement Disorders Research Registry and had received genetic counseling in the past were 
also invited to participate. Additionally, the Huntington Disease Society of America Inc. Western 
Pennsylvania Chapter holds a monthly support group in the city of Pittsburgh. Individuals who 
had previously received genetic counseling services through the HD Clinic and currently attend 
the support group meetings were also invited to participate. 
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2.2 INSTRUMENTATION  
2.2.1 Survey Design  
The final draft of the survey instrument, which can be seen in Appendix C, was constructed and 
adapted from the comprehensive measure of satisfaction instrument seen in Appendix D 
developed by Shiloh et al. (1990). Primary author, Dr. Shoshana Shiloh, gave her written 
permission for the use of the Satisfaction with Genetic Counseling instrument in this study. 
Shiloh et al. (1990) instrument was adapted to include all of the relevant questions pertaining to 
the genetic counseling services offered in the Huntington Disease Clinic of UPMC in Pittsburgh, 
Pennsylvania.  
 The survey was evaluated several times by Robin E. Grubs, MS, PhD, LCGC, a leader in 
the field of outcome research in genetic counseling. The primary author of this thesis project, 
Alicia Martinez, BS, worked in collaboration with Robin Grubs, MS, PhD, LCGC to add, 
remove, and restructure questions in the survey making it appropriate for participants from the 
HD population. Genetic epidemiologist, John R. Shaffer, PhD, recommended and assisted in 
constructing the Likert scale, which is the psychometric scale measuring levels of 
agreement/disagreement used for the responses to the questions in the survey.  
The first part of the survey consisted of an introduction, served the purpose of describing 
the study to the participants and its purpose of evaluating patient satisfaction with genetic 
counseling services. It provided the participants with the names of the two genetic counselors 
who have provided these services in the HD Clinic over the years, Betsy Gettig, LCGC and 
Christa Lorenchick, CGC. The introduction also provided the participants with basic instructions 
on filling out the survey and stressed that responses would be anonymous. The HD population in 
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Pittsburgh, PA is relatively small; therefore, there was the potential for participants to feel 
uncomfortable answering questions in the survey if they felt their answers would not be 
anonymous. It was described in the introduction that there were no foreseeable risks associated 
with the study, nor were there any direct benefits to the participants. The introduction outlined 
that participation in the study was voluntary and individuals were given the opportunity to opt 
out at any time.  
The main body of the survey instrument was comprised of 26 questions, demographic 
questions, and two open-ended questions. Demographic questions asked age, gender, reason for 
current/last visit to the clinic, and who is completing the survey. Additional questions were 
targeted toward analyzing participants’ feelings toward the genetic counseling services they had 
received in clinic. Participants were given the opportunity to choose “N/A” if a question was not 
applicable to their experience with these services. They were asked to provide commentary 
regarding the satisfaction with the genetic counseling services they received as well as their 
satisfaction with the genetic counselor who delivered the services to determine any trends in 
data.   
Participants who completed the paper version of the survey were given the option of 
omitting answering certain questions as well as choosing more than one answer for a given 
question. The online version of the survey through Qualtrics Survey System prohibited 
participants from moving on to different parts of the survey without completing every question.  
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2.2.2 Recruitment E-mail 
E-mails were drafted and sent out to invite individuals to participate in an electronic version of 
the survey if they did not attend the Huntington Disease Clinic of UPMC on a monthly basis. A 
copy of the initial e-mail and reminder e-mail can be seen in Appendix B.1 and B.2. The social 
workers for the HD Clinic, Peggy Humbert and Tammy Makoul, and Larry Ivanco, MSW, BSC 
sent out the e-mails to participants in order to ensure anonymity.  
2.3 PROCEDURES  
2.3.1 Survey Distribution  
Surveys were distributed to willing participants by two different means. Individuals affected with 
Huntington disease and their families who attend the monthly Huntington Disease Clinic of 
UPMC and received genetic counseling services were given paper versions of the survey. This 
version of the survey was distributed to the participants by the healthcare professionals who 
contribute to the care of the patient and their families in the HD Clinic. Valerie Suski, DO, the 
neurologist for the clinic, and the social workers, Tammy Makoul and Peggy Humbert, 
distributed the survey to participants in the clinic.  
 For those individuals and their families who do not attend the HD clinic on a regular 
basis, the survey was made available electronically through the University of Pittsburgh’s 
Qualtrics Survey System. An e-mail was sent by Larry Ivanco, MSW, BSC and the social 
workers to individuals in the Pittsburgh Institute for Neurodegenerative Diseases (PIND) 
 22 
Movement Disorders Research Registry and the Huntington Disease Society of America Inc. 
Western Pennsylvania Chapter monthly support group respectively with an anonymous link to 
the electronic survey. Some individuals at the monthly support group received a paper copy of 
the survey to be filled out during the support group, which was distributed by the social workers. 
The primary author of this project did not handle the distribution of the survey to maintain 
anonymity.  
The individuals with the role of distributing the survey to participants had to strategically 
determine whom to offer to complete the survey. The inclusion/exclusion process had to be 
completed because some current patients of the clinic have not received genetic counseling 
services and thus would not be appropriate candidates for this study. 
2.3.2 Results Collection 
Responses to the survey were collected electronically and through the gathering of the completed 
paper versions of the survey. Several surveys were distributed to participants by hand during 
clinic and responses were received by mail. In this circumstance, participants returned the survey 
with an unmarked envelope without a return address to the social workers in order to ensure 
anonymity. The primary author of this project did not handle collecting the paper surveys 
directly from the participants in order to maintain anonymity.  
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2.4 STATISTICAL ANALYSIS  
Quantitative statistical analysis of data obtained from this study was completed under the 
guidance of a genetic epidemiologist at the University of Pittsburgh. Microsoft Excel® was the 
tool used to compile the raw data exported from Qualtrics Survey System and the paper versions 
of the survey. Much of the descriptive statistics was performed through Microsoft Excel® 
analysis tools; however some values were computed by hand. The primary author attempted to 
analyze the responses to the open-ended questions by categorizing the responses into themes. 
The themes were utilized in order to gain additional patient perspectives about satisfaction with 
genetic counseling services that were otherwise not captured through the 26 multiple-choice 
questions of the survey.  
The Likert scale was scored 1-5 for analysis of ‘positive’ worded questions of the survey: 
“Strongly agree” = 5, “Agree” = 4, “Neither agree nor disagree” = 3, “Disagree” = 2, and 
“Strongly disagree” = 1. For ‘negative’ worded questions, a reverse scoring method was used for 
analysis: “Strongly disagree” = 5, “Disagree” = 4, “Neither agree nor disagree” = 3, “Agree” = 2, 
“Strongly agree” = 1.  Participants were given the opportunity to answer questions with “N/A” if 
the question did not apply to the genetic counseling services they received at the Huntington 
Disease Clinic. In the circumstance where participants chose “N/A” for a question, the response 
was not included as part of the analysis. When a participant did not answer a certain question, 
that question was also not included as part of the analysis.  
Of note, one participant partially completed an online version of the survey through the 
Qualtrics Survey System. This participant’s responses were not included in the data analysis.  
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2.4.1 Likert Scales and Data Analysis  
A commonly debated topic is proper statistical analysis of Likert scale data. Specifically, 
disagreement exists in the literature upon whether Likert items should be considered ordinal data 
or interval data. Ordinal data is a statistical data type consisting of numerical scores that exist on 
an arbitrary numerical scale with the purpose of ranking data points. Interval data is a statistical 
data type that generally consists of integer data where ordering and distance measuring between 
data points is possible (Norman, 2010). 
The desired analysis for this project was to measure general satisfaction of genetic 
counseling in the Huntington Disease Clinic by using normal statistical procedures, including 
computing the normal mean and normal confidence intervals around the mean. Some will argue 
that Likert scales consisting of asymmetric categories, representing ordinal-type data, inhibit the 
use of normal statistics due to potential bias toward a specific outcome or categories that are not 
equidistant. However, Likert scales presenting with symmetry of categories about a midpoint are 
argued to behave like interval-type data where normal statistical procedures can be utilized 
(Norman, 2010).  
In this study, a Likert scale was constructed to include symmetric categories about a 
midpoint. The investigators in this study assumed the Likert scale utilized approximated interval 
data and used normal statistical procedures for the data analysis.  
2.4.2 Genetic Counseling Satisfaction Survey Questions  
Table 2 lists the 26 questions that were that were asked in the genetic counseling satisfaction 
survey that utilized the Likert scale for which participants could choose their response. For sake 
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of ease, it can be referenced when viewing tables and figures to view the full question that 
corresponds to the question number.  
 
Table 2. Genetic Counseling Satisfaction Survey Questions  
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3.0  RESULTS  
3.1 DEMOGRAPHICS 
Approximately 50 individuals were invited to participate in the study, and of these individuals, 
33 agreed to participate and completed the survey. Thus, the response rate was approximately 
66%. The majority of the participants completed the paper version of the survey (87.9%; n=29). 
Four individuals (12.1%) completed the electronic version of the survey through the University 
of Pittsburgh’s Qualtrics Survey System. Of the 33 participants, 22 were female (67%) and 11 
were male (33%). The mean age of participants who completed the survey was 47 years with the 
range being from 23 to 74 years.   
 
Figure 1. Individual Who Completed Survey 
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Sixteen participants were patients of the Huntington Disease Clinic of UPMC who were 
either symptomatic or asymptomatic, as can be seen in Figure 1. Eleven were family members 
(individuals at-risk based on a family history of HD) and nine were caregivers.  
3.2 SATISFACTION DATA  
To complete the second aim of the study, descriptive statistics and analysis of open-ended 
responses was conducted. 
3.2.1 Descriptive Statistics  
Table 3. Responses to Questions by Counts and Percentages 
 
In order to assess general satisfaction, participants were asked to rate how they felt about each 
question related to their genetic counseling services ranging from strongly agree to strongly 
disagree. Table 3 displays the responses to questions 1-26 in counts and percentages. Two (6%, 
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n=33) or fewer participants responded negatively to each question. Table 3 does not reflect the 
reverse scoring method used for the ‘negative’ worded questions, 13 and 24. Figure 2 is an 
alternative way of presenting the satisfaction data. It is a graphical representation of the mean 
response for questions 1-26 with 95% confidence intervals. Each response was scored 1-5, with 
‘Strongly agree’ corresponding to a score of 5 and ‘Strongly disagree’ corresponding with a 
score of 1 for ‘positive’ worded questions. For the ‘negative’ worded questions, a reverse scoring 
method was utilized and also depicted in Figure 2. In this case, ‘Strongly disagree’ corresponded 
to a score of 5 and ‘Strongly agree’ corresponded to a score of 1. The mean response for each 
question is depicted below. The mean response for all of the questions combined was 4.59 on the 
scale of 1-5.  
 
Figure 2. Mean Responses and Confidence Intervals for Q1-Q26 (95%) 
3.2.1.1 Subscales  
In order to further assess satisfaction, the results were stratified into subscales that appraised two 
specific components of a genetic counseling session in the HD Clinic. The first subscale includes 
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all of the questions in the survey that were centered around assessing inherent characteristics of 
the genetic counselor, i.e. the counselor’s affect, genetic expertise on Huntington disease, and 
whether the genetic counselor provided a setting that was comfortable for the patient to discuss 
themselves or their family members. The second subscale focuses on assessing the responses to 
the questions in the survey that were centered on the patient’s perceptions during/after the 
counseling services, i.e. whether the patient considered going to another genetic counselor for 
services, whether the counselor met the patient’s expectations, and their overall satisfaction with 
the counseling. Table 4 below shows the stratification of questions in the survey into subscales. 
To view the entire question corresponding to the question number, please reference Table 2 
above.  
    Table 4. Subscales 
 
 
In order to assess general satisfaction of the two subscales, mean and error bars were 
computed for each subscale. The mean for each subscale was calculated by averaging the mean 
responses from Figure 2 for each question in a subscale. The mean response for each subscale 
was greater than 4.5. Figure 3 below shows the mean and 95% confidence intervals for each 
subscale.  
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 Figure 3. Subscale Mean Response and Confidence Intervals (95%) 
3.2.2 Open-Ended Responses   
Participants were asked to comment on their general satisfaction with specific components of the 
genetic counseling services they had received in two open-ended questions. The responses to 
these questions were categorized into themes. The first open-ended question focused on specific 
components of the counseling that the participant was most satisfied with. Tables 5, Table 6, and 
Table 7 contain participants’ responses to the first question. The three themes that emerged 
through the analysis include attributes of the genetic counselor, general feelings of satisfaction, 
and the setting of the counseling. The comments elicited from the first open-ended question 
support the hypothesis that patients in the HD Clinic are generally satisfied with the genetic 
counseling services they have received. The first question read as follows: “Please comment on 
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how satisfied you were with the counseling services you received and what you were most 
satisfied with.”  
Table 5. Open-Ended Responses Question 1, Theme 1 
 
 
Table 6. Open-Ended Responses Question 1, Theme 2 
 
 
Table 7. Open-Ended Response Question 1, Theme 3 
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The second open-ended question focused on asking participants to comment on the 
genetic counselor and their general satisfaction with her. The question was constructed in order 
to have participants comment on specific attributes about the genetic counselor that they found to 
be most effective and attributes with which they were most satisfied. The second question read as 
follows: “Please comment on your satisfaction with the genetic counselor who provided you with 
the genetic counseling services, i.e. what did you like most about the genetic counselor?” Table 8 
and Table 9 contain all of the participants’ responses to the second open-ended question. The two 
themes that emerged through the analysis include inherent characteristics of the genetic 
counselor and general feelings of satisfaction. Participants’ responses to the second open-ended 
question support the hypothesis of this research study. 
 
Table 8. Open-Ended Response Question 2, Theme 1  
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Table 9. Open-Ended Response Question 2, Theme 2 
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4.0  DISCUSSION 
The results from the client satisfaction survey were utilized in evaluating the effectiveness of 
genetic counseling services in the UPMC HD Clinic to accomplish the first aim of this research 
study. The results were statistically analyzed to achieve the second aim of the study to determine 
support for the study’s hypothesis. The results of the study suggest that the patients in the UPMC 
HD Clinic are generally satisfied with the genetic counseling services they have received. 
Services in the HD clinic have not been evaluated prior to this study, and this research has the 
potential to inform the provision of services in the clinic. Additionally, this study has the 
potential to inform genetic counseling outcome studies in other settings.  
4.1 DEMOGRAPHICS 
Approximately 50 individuals were invited to participate in this study through the two means of 
survey distribution, i.e. paper version and online format. Thirty-three participants agreed to 
participate in the study and subsequently completed the survey. The majority of the participants 
were female (67%, n=33) and the average age of participants who completed the survey was 47.  
 The majority of participants completed the paper version of the survey, and most were 
current patients of the UPMC HD Clinic. A few participants chose more than one answer when 
answering the question of who was filling out the survey. It is possible that a participant is 
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someone who is at-risk for developing HD and is also a caregiver. Additionally, two participants 
omitted answering this question. For this reason, the number of individuals in Figure 1 does not 
reflect a total of 33 responses. A total of 36 participants were included in the analysis of the 
demographics. 
4.2 DESCRIPTIVE STATISTICS  
The data support our hypothesis that patients are generally satisfied with the genetic counseling 
services in the UPMC Huntington Disease Clinic. General satisfaction was measured according 
to a Likert scale scored from 1-5. Five on the scale represents the highest level of satisfaction 
with the genetic counseling services, and one represents the lowest level of satisfaction. The 
mean response for each question asked in the survey was greater than 4.18. The mean response 
for all of the questions combined was 4.59 on the scale of 1-5. This corresponds to a high level 
of patient satisfaction with the counseling services in the clinic.  
The data were further stratified into subscales with the intent of evaluating the multiple 
choice questions that were focused on satisfaction with inherent characteristics of the genetic 
counselor and those that were centered on patient’s perceptions during/after the counseling 
services. The mean response for all of the questions in the first subscale was 4.60. The mean 
response for all of the questions in the second subscale was 4.58. These findings suggest that the 
participants in the study were generally highly satisfied with the genetic counselor providing the 
counseling services as well as the counseling itself.  
Limited research exists on client satisfaction of genetic counseling services in the 
Huntington disease population. Furthermore, limited studies exist on client satisfaction in any 
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setting offering genetic counseling services. However, our data compared similarly with others in 
the literature measuring global client satisfaction with genetic counseling services in other 
settings. Shiloh et al. (1990) determined that the mean level of satisfaction in their study was 
3.13 on a scale of 1-4. Davey et al. (2005) evaluated genetic counseling services provided by 
Genetic Services of Western Australia (GSWA) by utilizing several different outcome measures, 
one being client satisfaction. These researchers measured client satisfaction using the instrument 
developed by Shiloh et al. (1990). Overall, satisfaction of genetic counseling services was 
measured to be 3.7 on a 4-point scale, corresponding to relatively high global satisfaction with 
genetic counseling services.  
Davey et al. (2005) reported in their study that participants felt there were two 
components of their genetic counseling services that were essential in their satisfaction with 
these services. The first component, the instrumental component of satisfaction, describes the 
genetic counselor as a competent source of knowledge. The second component, the affect 
component of satisfaction, addresses the manner in which patients felt the counselor related to 
them as a person. The data in our study support this same finding. Approximately 97% of 
participants either strongly agreed or agreed that the genetic counselor was an expert in HD. The 
majority of participants also responded either strongly agreed or agreed to questions in our 
survey that pertained to the affect component of satisfaction. These findings would also support 
an argument that the instrumental and affect components to satisfaction are important 
components to patients’ general satisfaction with genetic counseling services.  
While this study demonstrated that overall clients are satisfied with genetic counseling 
services in the HD Clinic, it also identified an area for improvement or need for further 
exploration. Approximately 18% (6, n=33) of participants responded that they neither agreed nor 
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disagreed to question 21. Question 21 addressed whether the genetic counselor lessened the 
client’s worries. This finding could suggest several possibilities. One possibility is that the 
counselor is not sufficiently addressing the clients’ worries in the clinic. Another possibility is 
that the client responded with ‘neither agree nor disagree’ because the client did not have any 
worries at the time they were receiving genetic counseling and answered the survey question in a 
neutral manner for this reason. In addition, a client’s worries/concerns may be difficult to 
mitigate regarding HD because some worries are unable to be assuaged, even by the most 
experienced genetic counselor. Regardless, this finding suggests an area for possible 
improvement in genetic counseling services, keeping in mind the challenge of generalizing this 
finding due to the small patient population (see Study Limitations below). Acknowledging this 
finding, genetic counselors may wish to pay extra attention to ensure that they are addressing 
client’s concerns/worries when delivering genetic counseling services.  
4.3 OPEN-ENDED QUESTION RESPONSES 
The responses to the open-ended questions of the survey were categorized into themes in order to 
identify additional patient perspectives that may not have been captured in the 26 multiple choice 
questions of the survey. The majority of the responses contributed to the assessment of high 
general satisfaction with genetic counseling services in the UPMC HD Clinic. The themes that 
emerged from the analysis of the open-ended responses revealed that attributes and inherent 
characteristics of a genetic counselor play a significant role in client satisfaction with services.  
Additionally, one response commented on the setting of the delivery of services being less 
comfortable than what the participant had expected, but it did not affect the outcome of the 
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services. This response provides insight into another possible area of improvement. The 
researchers assessed this response and concluded that the participant who commented negatively 
on the setting where the genetic counseling took place would favor a room with greater space. 
Improving the setting where the genetic counseling takes place in the UPMC Huntington Disease 
Clinic has the potential to increase the overall satisfaction of services.  
4.4 STUDY LIMITATIONS 
This was an exploratory study that aimed at examining participant perceptions of genetic 
counseling services by measuring client satisfaction with these services. Some potential 
limitations to the study-design are noted here. Participants in the study were given the 
opportunity to complete the survey and were also able to opt out of the study at any time. Self-
selection bias has to be acknowledged for this reason. Additionally, the sample size was 
relatively small in this study and not chosen in an unbiased way. Due to these reasons, 
generalizations about satisfaction with genetic counseling services in this setting as well as other 
settings cannot be made. This is because this small sample size is likely not representative of all 
participants who receive genetic counseling either in a predictive testing setting, such as HD, or 
other settings where genetic counseling is offered. Additionally, participants in the study were 
chosen by the neurologist and social workers in the clinic in order to recruit those that have 
received genetic counseling services. Considering selection for this study was not random, bias 
could be introduced in this way. Trends observed in this study would be better supported in a 
study with a larger sample size and whose selection for recruitment is random. Rather, these 
 39 
findings could be used to examine particular aspects of genetic counseling in which patients are 
satisfied with and could be used inform further research on the topic.  
 Another aspect of the study design that made interpretation difficult was the design of the 
instrument itself.  The structure and wording of the questions posed difficulties for several 
participants completing the survey. The researchers rescored two of the participants’ responses 
due to inconsistencies with their responses to the multiple-choice questions and open-ended 
questions. For example, these two participants expressed high satisfaction with the genetic 
counseling services in the open-ended questions, but their responses to all of the multiple choice 
questions reflected low levels of satisfaction. In other words, these participants’ responses were 
either a 1 or 2 on our scale of 1-5.  The researchers attributed these discrepancies to the 
participants not completely reading the multiple-choice answers before answering the question. 
Therefore, the researchers found it appropriate to rescore them. Moreover, there were some 
outliers in the data, i.e. responses to questions that reflected low satisfaction in a patient’s survey 
that otherwise had responses reflecting a high level of satisfaction in all other questions. The 
researchers did not rescore these questions, but it is possible these findings could be a result of 
the participant not fully reading the multiple-choice question and/or the responses.  
 Another aspect of the study that limited the interpretation is the inconsistency between 
the two means of survey distribution. Mixed-mode surveys (i.e. utilizing more than one mode of 
data collection) are relatively common in research practices. Debate in the literature exists over 
potential advantages and disadvantages to this approach. Several advantages are that this 
approach may increase response rate as well as reduce survey “non-response error”. (Brogger et 
al, 2002). Some disadvantages to this approach may exist in relation to the “mode effects”, which 
refer to the differences in the way respondents answer questions in the survey depending on what 
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mode of data collection that is being used. Other disadvantages could be survey errors that are 
influenced by the mode of data collection. Non-response and sampling errors are an example of 
this. In our study there were some survey errors and inconsistencies between the modes of data 
collection. Participants completing the online survey were forced to answer questions before 
proceeding to the next question or part of the survey. This holds true for the open-ended 
questions in the electronic version. Individuals who were filling out the paper version of the 
survey were not forced to answer a question before proceeding on. Hence, individuals filling out 
the paper-version were able to skip answering a question. Furthermore, individuals filling out the 
electronic version of the survey were not permitted to choose multiple answers for demographic 
questions. Several participants who completed the paper version responded with several answers 
to the demographic questions. These inconsistencies could result in data analysis that is not 
completely accurate. However, in concordance with the conclusions made in a study by Meckel 
et al. 2005 the researchers felt that the advantages of this mixed-mode survey justified and took 
precedence over the disadvantages. Future studies should pay particular attention to ensure that 
all modes for survey distribution are consistent and congruent.    
A second major limitation to this study is that the intent focused primarily on assessing 
general satisfaction with genetic counseling services and not satisfaction with the genetic 
counseling process itself. The majority of outcome research on genetic counseling services has 
the intent of providing suggestions for the ways in which the services could be improved. While 
this study elicited some suggestions for improving services, i.e. the setting that the counseling is 
delivered or addressing client’s worries/concerns, a study focused on investigating the genetic 
counseling process itself could yield greater suggestions for improvements of this process 
(Davey et al., 2005). Lastly, a study that is comprised of participants who better represent patient 
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populations that present for genetic counseling would better inform potential proficiencies and 
improvements in genetic counseling services.  
4.5 FUTURE RESEARCH RECOMMENDATIONS  
In the future, it would possibly be beneficial to embark on a more complete quantitative analysis 
of patient satisfaction potentially utilizing a random sample and more advanced statistical 
procedures for data analysis. This might be helpful in identifying specific aspects of counseling 
that are most satisfying for patients or most consistently achieve the desired outcomes. 
Additionally, it may be useful to incorporate a qualitative approach in an outcome study. With its 
ability to explore complex social processes and elicit participants’ experiences in rich detail 
(Beeson, 1997), qualitative research would allow for a more robust understanding on patients’ 
perspectives of their genetic counseling experience. Moreover, qualitative research has the 
potential to identify issues that were not anticipated by researchers (Beeson, 1997) and therefore, 
may uncover aspects of genetic counseling outcomes that generate novel ideas. Future studies 
could also employ a different measure to obtain patient perspectives on other outcomes of 
counseling in a predictive testing setting, such as HD.  
 A study focused on investigating the genetic counseling process itself could yield 
suggestions for improvements of genetic counseling services. According to Biesecker and Peters, 
2001: “Process studies investigate the content, behavior and relationships that make up genetic 
counseling sessions. They strive to answer questions about what happens in practice and how it 
works.” In contrast, outcome studies “…assess measurable changes in client outcomes as a result 
of genetic counseling.” (Biesecker and Peters, 2001). Future studies may employ combining 
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process studies and outcome studies using quantitative approaches to analyze potential impacts 
of genetic counseling process on client outcomes (Meiser et al. 2008). Results from this study 
utilizing this approach could yield potential improvements of genetic counseling services 
because the content of a genetic counseling session may affect patient perceptions of the 
counseling as well as more broadly affect the outcome of the counseling services (Butow and 
Lobb 2004, Biesecker and Peters 2001, Clarke et al. 1996, Meiser et al. 2008).   
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5.0  CONCLUSION 
This study had the aim of eliciting patient perspectives of satisfaction with genetic counseling 
services in the UPMC Huntington Disease Clinic in Pittsburgh, Pennsylvania. Minimal outcome 
research has been conducted in the HD setting, and this study provided an opportunity to gather 
information on patient perspectives of genetic counseling services in a predictive testing setting 
such as HD. Outcome research in genetic counseling in any setting is important to evaluate the 
services to ensure that they are being provided in a satisfactory manner and may even identify 
avenues for improvement of these services. The researchers felt that the most appropriate 
outcome measure for this research study was client satisfaction.  
Research on client satisfaction with genetic counseling service is needed as the profession 
grows and becomes more integrated into health care. Genetic counselors with their expertise in 
molecular diagnostics are expected to play an increasingly important role in medicine, as 
genomics continues to become incorporated into health care. Ascertaining patient perceptions of 
genetic counseling services can help ensure that counseling is meeting the needs of patients and 
can identify areas for continued improvement.  
While changes within the genetic counseling profession were part of the rationale for 
choosing client satisfaction for this study, the study population was an additional consideration. 
Huntington disease is a debilitating disorder, with psychiatric disturbances and diminished 
cognitive abilities being common features. Outcome measures requiring client information recall 
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after receiving genetic counseling or measures evaluating psychological impact of genetic 
counseling may be challenging in the HD population due to the characteristic features. However, 
assessing client satisfaction utilizing the instrumental and affect component of satisfaction was 
felt to be appropriate for this population in this study. The ease of obtaining satisfaction data is 
ideal in a population where diminishing mental capacity is of concern. Responding to questions 
in a survey that are targeted to the instrumental and affect components of satisfaction does not 
typically require high cognitive abilities. In essence, it requires the patient to reflect back to the 
genetic counseling services they have received and evaluate their feelings about these services. 
For these reasons, client satisfaction was felt to be an effective way of gaining patient 
perceptions of genetic counseling services in the UPMC HD Clinic.  
As anticipated, the researchers discovered that patients are generally satisfied with the 
genetic counseling services in the HD Clinic. On a scale of 1-5, the mean satisfaction of the 
services was determined to be 4.59. These results compared similarly with other outcome studies 
utilizing client satisfaction. The stratification of the results of this study indicated that patients 
are generally satisfied with inherent characteristics of the counselor herself, as well as the 
counseling. This research also uncovered some potential areas for improvement. One participant 
commented that the setting of their genetic counseling was not comfortable. This may have 
decreased the participant’s overall satisfaction with the services. The researchers recommend that 
genetic counselors pay particular attention to the setting where they are delivering services to 
ensure that the setting is comfortable for the patient. Additionally, responses to the survey 
elicited concerns that the genetic counselor was not sufficiently addressing the worries of the 
client. This raises opportunities for potential improvement of services. Genetic counselors may 
wish to pay particular attention during their counseling sessions to address worries/concerns that 
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the patient expresses. A way to achieve this could be to directly ask the patient to express any 
worries/concerns they have during contracting, an important component of the genetic 
counseling process. While there are limitations and challenges of generalizing the findings of this 
study due to the small study population chosen in a biased manner, these findings have local 
relevance of elucidating potential improvements of genetic counseling services in the HD clinic, 
which is important to ensure that the counseling in the clinic is meeting patient expectations. The 
findings from this study can also inform further research on this topic.  
 The information gathered from this research is of particular significance to the field of 
public health because genetic counseling is expected to play an important role in providing 
personalized and preventative health care. As O’Daniel notes (2010), “With expertise in genetic 
science, risk assessment and communication, and a patient-centered practice approach, genetic 
counselors are poised to play a critical role in facilitating the incorporation of genomic health 
risks into the burgeoning field of genome-guided preventative medicine.” As the profession 
continues to grow and genome-based testing (Mills and Haga, 2013) expands, it is increasingly 
important to assess the provision of genetic counseling services to ensure that it is meeting the 
needs of patients. This study explored patient perspectives in one clinic setting and determined 
that the participants were satisfied with their genetic counseling experience. This research may 
inform outcome research in other settings.  
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